Key drivers for each region include: for North America, high adoption of advanced diagnostic technologies, favorable policies and investments in healthcare infrastructure, and a mature ecosystem for research and development; for Europe, increasing demand for accurate diagnostic tests, growing infrastructure for healthcare services, and favorable regulations for medical devices; for Asia Pacific, increasing demographics and growing infrastructure for healthcare services, rising awareness of fungal infections, and expanding distribution networks for diagnostic kits; for Latin America, growing infrastructure for healthcare services, increasing demand for diagnostic tests, and rising awareness of fungal infections; and for Middle East & Africa, increasing demand for diagnostic tests, growing infrastructure for healthcare services, and rising awareness of fungal infections.